FARALLON CAPITAL MANAGEMENT LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$371,998
-22.0%
2,2000.0%0.00%0.0%
Q2 2023$477,070
+19.4%
2,2000.0%0.00%0.0%
Q1 2023$399,608
-7.6%
2,2000.0%0.00%
-33.3%
Q4 2022$432,300
-97.6%
2,200
-97.2%
0.00%
-97.0%
Q3 2022$17,994,000
+42.2%
80,000
-20.0%
0.10%
+44.9%
Q2 2022$12,651,000
-71.5%
100,000
-71.4%
0.07%
-67.8%
Q1 2022$44,377,000
-38.4%
350,000
-36.4%
0.21%
-40.6%
Q4 2021$72,050,000
-15.9%
550,000
-21.4%
0.36%
-10.0%
Q3 2021$85,631,000
+19.2%
700,000
+11.1%
0.40%
+36.5%
Q2 2021$71,814,000
-11.5%
630,000
-6.7%
0.29%
-27.3%
Q1 2021$81,155,000
+14.1%
675,000
-3.6%
0.40%
-5.8%
Q4 2020$71,113,000
+31.4%
700,0000.0%0.43%
+14.4%
Q3 2020$54,124,000
-15.6%
700,000
+21.7%
0.37%
-27.1%
Q2 2020$64,090,000
+57.0%
575,000
+1.4%
0.51%
+46.6%
Q1 2020$40,827,000
-9.7%
567,047
-5.5%
0.35%
+14.8%
Q4 2019$45,204,000600,0000.30%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,912,872$369,323,00052.78%
Pivotal bioVenture Partners Investment Advisor LLC 852,708$108,115,00051.15%
Sofinnova Investments, Inc. 1,953,077$247,631,00018.79%
Nan Fung Group Holdings Ltd 234,811$29,772,00014.12%
Sands Capital Ventures, LLC 267,895$33,966,0007.10%
Logos Global Management LP 340,000$43,109,0005.59%
DAFNA Capital Management LLC 82,053$10,403,0002.71%
Ghost Tree Capital, LLC 60,000$7,607,0001.65%
CATALYST PRIVATE WEALTH, LLC 24,976$3,167,0001.58%
Eventide Asset Management 748,000$94,839,0001.49%
View complete list of KARUNA THERAPEUTICS INC shareholders